Miss Milly Bennett
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
| Year | Citation |
|---|---|
| 2026 | Bennett, M. G. A., Meakin, A. S., Botting-Lawford, K. J., Niu, Y., Ford, S. G., Murphy, M. P., . . . Morrison, J. L. (2026). Chronic hypoxia or MitoQ treatment in pregnancy independently alter hepatic cytochrome P450 activity in fetal sheep and 9-month-old lambs. Biochemical Pharmacology, 243(Pt 1), 13 pages. |
| 2025 | Bennett, M. G. A., Meakin, A. S., Botting-Lawford, K. J., Niu, Y., Ford, S. G., Murphy, M. P., . . . Morrison, J. L. (2025). Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone. Pharmaceutics, 17(3), 16 pages. Scopus2 WoS2 Europe PMC2 |
| Year | Citation |
|---|---|
| 2024 | Bennett, M. G. A., Meakin, A. S., Botting, K. J., Niu, Y., Ford, S. G., Murphy, M. P., . . . Morrison, J. L. (2024). MitoQ Treatment During Pregnancy Rescues Antenatal Dexamethasone- Induced Programming of Impaired Hepatic CYP Activity in Young Adult Sheep.. In REPRODUCTIVE SCIENCES Vol. 31 (pp. 146A). CANADA, Vancouver: SPRINGER HEIDELBERG. |